Ken Griffin Mimedx Group, Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 34,600 shares of MDXG stock, worth $212,098. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,600
Previous 102,700
66.31%
Holding current value
$212,098
Previous $790,000
69.75%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding MDXG
# of Institutions
221Shares Held
95.4MCall Options Held
115KPut Options Held
189K-
Essex Woodlands Management, Inc. The Woodlands, TX28.2MShares$173 Million63.89% of portfolio
-
Black Rock Inc. New York, NY9.31MShares$57.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.93MShares$42.5 Million0.0% of portfolio
-
Trigran Investments, Inc.4.48MShares$27.5 Million3.25% of portfolio
-
Paradigm Capital Management Inc4.17MShares$25.5 Million1.33% of portfolio
About MIMEDX GROUP, INC.
- Ticker MDXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 113,609,000
- Market Cap $696M
- Description
- MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...